Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 770 | 3,120 | 4,710 | 11,890 | 4,460 |
| Marketable Securities | 5,000 | 5,000 | 5,000 | 0 | 0 |
| Other current assets | 160 | 150 | 250 | 220 | 230 |
| TOTAL | $5,930 | $8,270 | $9,960 | $12,110 | $4,690 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 300 | 260 | 250 | 210 | 200 |
| TOTAL | $300 | $260 | $250 | $210 | $200 |
| Total Assets | $6,360 | $8,660 | $10,280 | $12,380 | $4,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 340 | 410 | 240 | 510 | 290 |
| Accrued Expenses | 510 | 680 | 630 | 630 | 1,080 |
| TOTAL | $5,980 | $6,340 | $7,060 | $6,060 | $1,380 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 390 | 2,290 | 5,250 | 9,910 | 0 |
| TOTAL | $390 | $2,290 | $5,250 | $9,910 | $N/A |
| Total Liabilities | $6,380 | $9,230 | $17,850 | $15,970 | $1,380 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 20 | 20 | 20 | 20 |
| Retained earnings | -25,720 | -24,950 | -30,630 | -33,730 | -26,430 |
| Other shareholders' equity | 0 | -9,820 | -9,820 | 10 | 10 |
| TOTAL | $-20 | $-570 | $-7,570 | $-3,590 | $3,580 |
| Total Liabilities And Equity | $6,360 | $8,660 | $10,280 | $12,380 | $4,960 |